Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial

RATIONALE AND AIMS: Monotherapy with antiplatelet agents is only modestly effective in secondary prevention of ischemic stroke (IS), particularly in patients with multiple risk factors such as cervicocephalic arterial stenosis, diabetes, and hypertension. While dual antiplatelet therapy (DAPT) with...

Descripción completa

Detalles Bibliográficos
Autores principales: Toyoda, Kazunori, Uchiyama, Shinichiro, Hoshino, Haruhiko, Kimura, Kazumi, Origasa, Hideki, Naritomi, Hiroaki, Minematsu, Kazuo, Yamaguchi, Takenori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Protocols
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335602/
https://www.ncbi.nlm.nih.gov/pubmed/25487817
http://dx.doi.org/10.1111/ijs.12420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335602/
https://www.ncbi.nlm.nih.gov/pubmed/25487817
http://dx.doi.org/10.1111/ijs.12420

Ejemplares similares